Accelerated degradation of ibuprofen in tablets

Pharmaceutical Development and Technology

Volumn 15, Issue 6, 2010, Pages 636-643

  Cory, Wendy Clevenger ^a   Harris, Corbyn ^a   Martinez, Sabrina ^a  

^a Department of Teacher Education and Department of Sociology and Anthropology   (United States)

Author keywords

4 isobutylacetophenone; Degradation; Excipients; Ibuprofen

Indexed keywords

4 ISOBUTYLACETOPHENONE; CHEMICAL AGENT; EXCIPIENT; IBUPROFEN; MACROGOL; OXYGEN; POLYSORBATE 80; UNCLASSIFIED DRUG;

ARTICLE; DRUG DEGRADATION; DRUG STORAGE; DRUG STRUCTURE; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; LIGHT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; STORAGE TEMPERATURE; TABLET;

ACETOPHENONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG STABILITY; DRUG STORAGE; EXCIPIENTS; HUMIDITY; IBUPROFEN; POLYETHYLENE GLYCOLS; POLYSORBATES; TABLETS;

EID: 78149252044     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450903426518     Document Type: Article

References (16)

1. Ahuja S.Overview: Isolation and characterization of impurities. In: Ahuja S, Alsante KM, editors. Handbook of isolation and characterization of impurities in pharmaceuticals. San Diego, CA: Academic Press; 2003:1-25.
2. Waterman KC, Adami RC, Hong J.Impurities in drug products. In:Ahuja S, Alsante KM, editors. Handbook of isolation and characterization of impurities in pharmaceuticals. San Diego, CA: Academic Press; 2003:75-88.
3. Wasylaschuk WR, Harmon PA, Wagner G, Harman AB, Templeton AC, Xu H, Reed RA. Evaluation of hydroperoxides in common pharmaceutical excipients. J Pharm Sci 2007;96(1):106-116.
4. Asmus PA. Determination of 2-(4-isobutylphenyl)propionic acid in bulk drug and compressed tablets by reversedphase high-performance liquid chromatography. J Chrom 1985;331(1):169-176.
5. Castell JV, Gomez-Lechon MJ, Miranda MA, Morera IM. Photolytic degradation of ibuprofen toxicity of the isolated photoproducts on fibroblasts and erythrocytes. Photochem Photobiol 1987;46(6):991-996.
6. Miranda MA, Morera I, Vargas F, Gomez-Lechon MJ, Castell JV. In vitro assessment of the phototoxicity of anti-inflammatory 2-arylpropionic acids. Toxic in Vitro 1991; 5(5/6):451-455.
7. United States Pharmacopeia and National Formulary (USP 29-NF 24). Rockville, MD: United States Pharmacopeial Convention; 2006:1100.
8. Alsante KM, Freidman, RC, Hatajik TD, Lohr LL, Sharp TR, Snyder KD, Szczesny EJ.Degradation and impurity analysis for pharmaceutical drug candidates. In Ahuja S, Scypinski S, editors. Handbook of modern pharmaceutical analysis. San Diego, CA: Academic Press; 2001:85-172.
9. Reynolds DW, Facchine KL, Mullaney JF, Alsante KM, Hatajik TD, Motto MG. Available guidance and best practices for conducting forced degradation studies. Pharm Technol 2002;26(2):48-54.
10. US Food and Drug Administration. Q1B: Photostability Testing of New Drug Substances and Products, 1996. US Food and Drug Administration, Center for Drug Evaluation and Research Web site. Accessed 12 August 2009 from the website: .
11. Pretsch E, Clerc T, Seibl J, et al.Tables for spectral data for structure determination of organic compounds. 2nd ed. Heidelberg: Springer-Verlag; 1989:U10,U50.
12. Vargas F, Rivas C, Miranda MA, Bosca F. Photochemistry of the non-steroidal anti-inflammatory drugs, propionic acid-derived. Die Pharmazie 1991;46(11):767-771.
13. Lau E.Preformulation studies. In Ahuja S, Scypinski S, editors. Handbook of modern pharmaceutical analysis. San Diego, CA: Academic Press; 2001:173-233.
14. Wade A, Weller PJ, editors. Handbook of pharmaceutical excipients. Washington DC: American Pharmaceutical Association; 1994:355.
15. Wade A, Weller PJ, editors. Handbook of pharmaceutical excipients. Washington DC: American Pharmaceutical Association; 1994:376.
16. Jacobson-Kram D, McGovern T. Toxicological overview of impurities in pharmaceutical products. Adv Drug Del Rev 2007; 59:38-42.